These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9165608)

  • 1. Bioavailability and pharmacokinetics of desmopressin in elderly men.
    Hougaard C; Matthiesen TB; Rittig S; Djurhuus JC
    Scand J Urol Nephrol Suppl; 1997; 183():53-4. PubMed ID: 9165608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmopressin tablet treatment: factors influencing gastrointestinal absorption.
    Rittig S; Jensen AR; Jensen KT; Pedersen EB
    Scand J Urol Nephrol Suppl; 1997; 183():51-2. PubMed ID: 9165607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of desmopressin administered orally versus intravenously at daytime versus night-time in healthy men aged 55-70 years.
    Rembratt A; Graugaard-Jensen C; Senderovitz T; Norgaard JP; Djurhuus JC
    Eur J Clin Pharmacol; 2004 Aug; 60(6):397-402. PubMed ID: 15197520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacokinetic and pharmacodynamic comparison of desmopressin administered as whole, chewed and crushed tablets, and as an oral solution.
    Argenti D; Ireland D; Heald DL
    J Urol; 2001 May; 165(5):1446-51. PubMed ID: 11342894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of food intake on the pharmacokinetics and antidiuretic activity of oral desmopressin (DDAVP) in hydrated normal subjects.
    Rittig S; Jensen AR; Jensen KT; Pedersen EB
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):235-41. PubMed ID: 9579238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender differences in nighttime plasma arginine vasopressin and delayed compensatory urine output in the elderly population after desmopressin.
    Hvistendahl GM; Frøkiaer J; Nielsen S; Djurhuus JC
    J Urol; 2007 Dec; 178(6):2671-6. PubMed ID: 17945283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of 400 microg of oral desmopressin in elderly patients with nocturia, and the correlation between the absorption of desmopressin and clinical effect.
    Hvistendahl GM; Riis A; Nørgaard JP; Djurhuus JC
    BJU Int; 2005 Apr; 95(6):804-9. PubMed ID: 15794787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical and pharmacological model for explaining response to desmopressin.
    Nørgaard JP
    Scand J Urol Nephrol Suppl; 1999; 202():53-5. PubMed ID: 10573796
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative study of pharmacodynamics and bioavailability of 2 different desmopressin nasal sprays.
    Eller N; Kollenz CJ; Hitzenberger G
    Int J Clin Pharmacol Ther; 1998 Mar; 36(3):139-45. PubMed ID: 9562229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osmoregulation and desmopressin pharmacokinetics in enuretic children.
    Nevéus T
    Scand J Urol Nephrol Suppl; 1999; 202():52. PubMed ID: 10573795
    [No Abstract]   [Full Text] [Related]  

  • 11. Antidiuresis: a new concept in managing female daytime urinary incontinence.
    Robinson D; Cardozo L; Akeson M; Hvistendahl G; Riis A; Norgaard JP
    BJU Int; 2004 May; 93(7):996-1000. PubMed ID: 15142150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are repeated desmopressin treatment attempts successful?
    Wikström S; Tapper J
    Scand J Urol Nephrol Suppl; 1997; 183():33-4; discussion 34-5. PubMed ID: 9165603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of diabetes insipidus with Minirin. Switch from nasal to oral administration].
    Czernichow P
    Ann Endocrinol (Paris); 1998 Dec; 59(5):407-9. PubMed ID: 9949892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of long-term administration of oral desmopressin on the baseline secretion of antidiuretic hormone and serum sodium concentration for the treatment of nocturia: a circadian study.
    Bae JH; Oh MM; Shim KS; Cheon J; Lee JG; Kim JJ; Moon DG
    J Urol; 2007 Jul; 178(1):200-3. PubMed ID: 17499799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effect of intranasal desmopressin for men with benign prostatic hyperplasia and nocturia: preliminary results.
    Chancellor MB; Atan A; Rivas DA; Watanabe T; Tai HL; Kumon H
    Tech Urol; 1999 Dec; 5(4):191-4. PubMed ID: 10591256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desmopressin resistant nocturnal polyuria may benefit from furosemide therapy administered in the morning.
    De Guchtenaere A; Vande Walle C; Van Sintjan P; Donckerwolcke R; Raes A; Dehoorne J; Van Laecke E; Hoebeke P; Vande Walle J
    J Urol; 2007 Dec; 178(6):2635-9; discussion 2639. PubMed ID: 17945291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of oral desmopressin in children with primary nocturnal enuresis.
    Schulman SL; Stokes A; Salzman PM
    J Urol; 2001 Dec; 166(6):2427-31. PubMed ID: 11696804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and renal excretion of desmopressin after intravenous administration to healthy subjects and renally impaired patients.
    Agersø H; Seiding Larsen L; Riis A; Lövgren U; Karlsson MO; Senderovitz T
    Br J Clin Pharmacol; 2004 Oct; 58(4):352-8. PubMed ID: 15373927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pharmacokinetic and pharmacodynamic study of desmopressin: evaluating sex differences and the effect of pre-treatment with piroxicam, and further validation of an indirect response model.
    Odeberg JM; Callréus T; Lundin S; Roth EB; Höglund P
    J Pharm Pharmacol; 2004 Nov; 56(11):1389-98. PubMed ID: 15525445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evaluation of desmopressin in treatment of adolescent nocturnal enuresis.
    Derman O; Kanbur NO; Kinik E
    Int J Adolesc Med Health; 2004; 16(4):377-85. PubMed ID: 15712975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.